These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25781162)

  • 21. HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET.
    Chiozzini C; Toschi E
    Curr Drug Targets; 2016; 17(1):33-45. PubMed ID: 26302810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy restricts HIV-1 infection.
    Daussy CF; Beaumelle B; Espert L
    Oncotarget; 2015 Aug; 6(25):20752-3. PubMed ID: 26309074
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.
    Régulier EG; Reiss K; Khalili K; Amini S; Zagury JF; Katsikis PD; Rappaport J
    Int Rev Immunol; 2004; 23(1-2):25-59. PubMed ID: 14690854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
    Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
    Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications.
    Agrawal L; Louboutin JP; Strayer DS
    Virology; 2007 Jul; 363(2):462-72. PubMed ID: 17336361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.
    Díaz-Delfín J; Domingo P; Wabitsch M; Giralt M; Villarroya F
    Antivir Ther; 2012; 17(3):529-40. PubMed ID: 22301094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection.
    Guendel I; Meltzer BW; Baer A; Dever SM; Valerie K; Guo J; Wu Y; Kehn-Hall K
    Virol J; 2015 Mar; 12():40. PubMed ID: 25879655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-related proteins prolong macrophage survival through induction of Triggering receptor expressed on myeloid cells-1.
    Yuan Z; Fan X; Staitieh B; Bedi C; Spearman P; Guidot DM; Sadikot RT
    Sci Rep; 2017 Feb; 7():42028. PubMed ID: 28181540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism.
    Rumbaugh J; Turchan-Cholewo J; Galey D; St Hillaire C; Anderson C; Conant K; Nath A
    FASEB J; 2006 Aug; 20(10):1736-8. PubMed ID: 16807369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The elephant and the blind men: making sense of the seemingly multifaceted role of Blimp-1 in HIV-1 infection.
    Schulze Zur Wiesch J; Beisel C
    AIDS; 2015 Jan; 29(1):134-6. PubMed ID: 25562500
    [No Abstract]   [Full Text] [Related]  

  • 33. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of HIV-Tat protein to HIV-sequelae.
    McLaughlin JP; Paris JJ
    Curr HIV Res; 2015; 13(1):2. PubMed ID: 25817718
    [No Abstract]   [Full Text] [Related]  

  • 35. Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.
    Stevens PR; Gawryluk JW; Hui L; Chen X; Geiger JD
    Curr HIV Res; 2014; 12(6):378-87. PubMed ID: 25613139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
    Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
    Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.
    Cafaro A; Caputo A; Maggiorella MT; Baroncelli S; Fracasso C; Pace M; Borsetti A; Sernicola L; Negri DR; Ten Haaft P; Betti M; Michelini Z; Macchia I; Fanales-Belasio E; Belli R; Corrias F; Buttò S; Verani P; Titti F; Ensoli B
    J Med Primatol; 2000 Aug; 29(3-4):193-208. PubMed ID: 11085582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Tat-induced changes in synaptically-driven network activity adapt during prolonged exposure.
    Krogh KA; Green MV; Thayer SA
    Curr HIV Res; 2014; 12(6):406-14. PubMed ID: 25613136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FoxO4 negatively controls Tat-mediated HIV-1 transcription through the post-transcriptional suppression of Tat encoding mRNA.
    Oteiza A; Mechti N
    J Gen Virol; 2017 Jul; 98(7):1864-1878. PubMed ID: 28699853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 Tat protein exposure potentiates ethanol reward and reinstates extinguished ethanol-conditioned place preference.
    McLaughlin JP; Ganno ML; Eans SO; Mizrachi E; Paris JJ
    Curr HIV Res; 2014; 12(6):415-23. PubMed ID: 25760047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.